227 related articles for article (PubMed ID: 10438795)
1. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.
Tripp RA; Moore D; Jones L; Sullender W; Winter J; Anderson LJ
J Virol; 1999 Sep; 73(9):7099-107. PubMed ID: 10438795
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.
Tripp RA; Moore D; Winter J; Anderson LJ
J Virol; 2000 Feb; 74(4):1614-22. PubMed ID: 10644330
[TBL] [Abstract][Full Text] [Related]
3. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
Spender LC; Hussell T; Openshaw PJ
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
[TBL] [Abstract][Full Text] [Related]
4. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
5. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge.
Bembridge GP; Lopez JA; Bustos R; Melero JA; Cook R; Mason H; Taylor G
J Virol; 1999 Dec; 73(12):10086-94. PubMed ID: 10559323
[TBL] [Abstract][Full Text] [Related]
6. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
[TBL] [Abstract][Full Text] [Related]
7. Protection against respiratory syncytial virus infection by DNA immunization.
Li X; Sambhara S; Li CX; Ewasyshyn M; Parrington M; Caterini J; James O; Cates G; Du RP; Klein M
J Exp Med; 1998 Aug; 188(4):681-8. PubMed ID: 9705950
[TBL] [Abstract][Full Text] [Related]
8. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent.
Srikiatkhachorn A; Chang W; Braciale TJ
J Virol; 1999 Aug; 73(8):6590-7. PubMed ID: 10400756
[TBL] [Abstract][Full Text] [Related]
9. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus.
Hancock GE; Speelman DJ; Heers K; Bortell E; Smith J; Cosco C
J Virol; 1996 Nov; 70(11):7783-91. PubMed ID: 8892899
[TBL] [Abstract][Full Text] [Related]
10. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
11. CD4(+) T cell frequencies and Th1/Th2 cytokine patterns expressed in the acute and memory response to respiratory syncytial virus I-E(d)-restricted peptides.
Tripp RA; Hou S; Etchart N; Prinz A; Moore D; Winter J; Anderson LJ
Cell Immunol; 2001 Jan; 207(1):59-71. PubMed ID: 11161454
[TBL] [Abstract][Full Text] [Related]
12. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Virol; 1997 Jan; 71(1):678-85. PubMed ID: 8985399
[TBL] [Abstract][Full Text] [Related]
13. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.
Varga SM; Wissinger EL; Braciale TJ
J Immunol; 2000 Dec; 165(11):6487-95. PubMed ID: 11086089
[TBL] [Abstract][Full Text] [Related]
14. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
[TBL] [Abstract][Full Text] [Related]
15. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge.
Johnson TR; Johnson JE; Roberts SR; Wertz GW; Parker RA; Graham BS
J Virol; 1998 Apr; 72(4):2871-80. PubMed ID: 9525607
[TBL] [Abstract][Full Text] [Related]
16. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
Johnson TR; Parker RA; Johnson JE; Graham BS
J Immunol; 2003 Feb; 170(4):2037-45. PubMed ID: 12574374
[TBL] [Abstract][Full Text] [Related]
17. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.
Johnson TR; Hong S; Van Kaer L; Koezuka Y; Graham BS
J Virol; 2002 May; 76(9):4294-303. PubMed ID: 11932395
[TBL] [Abstract][Full Text] [Related]
18. Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.
Johnson TR; Varga SM; Braciale TJ; Graham BS
J Virol; 2004 Aug; 78(16):8753-60. PubMed ID: 15280483
[TBL] [Abstract][Full Text] [Related]
19. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
[TBL] [Abstract][Full Text] [Related]
20. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.
Boelen A; Andeweg A; Kwakkel J; Lokhorst W; Bestebroer T; Dormans J; Kimman T
Vaccine; 2000 Nov; 19(7-8):982-91. PubMed ID: 11115725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
